Cigna

Current directors and officers who also hold a role at another S&P 500 company.

• Kimberly A. RossKKR · DirectorNOC · Director
• Donna F. ZarconeCDW · Director
• George KurianNTAP · CEO
• Kathleen M. MazzarellaWM · Director
• Mark B. McClellanJNJ · Director
• Michael J. HenniganMPC · Chair
• Neesha HathiSCHW · Officer

Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.

No 5% holder filings parsed yet for this company.

Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.

Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.

1. Oct 9, 2026

   On October 6, 2026, Donna F. Zarcone informed the Board of Directors (the “Board”) of The Cigna Group (the “Company”) that she will retire from the Board effective December 31, 2026. Ms. Zarcone’s retirement is not the result of any disagreement with the Company.

   Read the 8-K filing
2. Mar 3, 2026

   Chief Executive Officer Succession On February 25, 2026, the Board of Directors (the “Board”) of The Cigna Group (the “Company”) appointed Mr. Brian C. Evanko as Chief Executive Officer (“CEO”) of the Company, effective July 1, 2026. Mr. Evanko will succeed Mr. David M. Cordani, who will retire as the CEO of the Company effective July 1, 2026. Mr. Cordani has been appointed Executive Chair of the Board, effective July 1, 2026. Mr. Evanko, 49, has served as President and Chief Operating Officer, The Cigna Group, since March 2025, Executive Vice President and Chief Financial Officer, The Cigna Group and President and Chief Executive Officer, Cigna Healthcare from January 2024 to March 2025; Executive Vice President and Chief Financial Officer, The Cigna Group from January 2021 to January 2024; President, Government Business from November 2017 to January 2021; and President, U.S.

   Read the 8-K filing
3. Oct 20, 2025

   On October 15, 2025, Retired Major General Elder Granger, M.D. informed the Board of Directors (the “Board”) of The Cigna Group (the “Company”) that he will retire from the Board effective December 31, 2025. General Granger’s retirement is consistent with the Board’s retirement age policy. General Granger’s retirement is not the result of any disagreement with the Company.

   Read the 8-K filing
4. Jul 28, 2025

   On June 2, 2025, The Cigna Group (the “Company”) filed a Current Report on Form 8-K announcing the action by the Company’s Board of Directors (the “Board”) on May 30, 2025 to appoint Michael J. Hennigan as an independent member of the Board, effective June 2, 2025. At the time of his appointment, the Board had not determined on which committees Mr. Hennigan would serve. This Form 8-K/A is being filed for the purpose of providing this information. On July 22, 2025, the Board appointed Mr. Hennigan to the Audit and Corporate Governance Committees.

   Read the 8-K filing
5. Jun 2, 2025

   On May 30, 2025, the board of directors (the “Board”) of The Cigna Group (the “Company”) appointed Michael J. Hennigan as an independent member of the Board, effective June 2, 2025. Mr. Hennigan will participate in the Company’s non-employee director compensation program, amended and restated effective July 24, 2024 (the “Plan”), as described in the Company’s Proxy Statement for the 2025 Annual Meeting of Shareholders, filed with the Securities and Exchange Commission (the “SEC”) on March 14, 2025. A copy of the Plan has been filed as Exhibit 10.14(c) to the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025. There is no arrangement or understanding between Mr. Hennigan and any other person pursuant to which Mr. Hennigan was selected as a director. There have been no transactions involving Mr.

   Read the 8-K filing
6. Apr 28, 2025

   On April 22, 2025, Ms. Noelle Eder, Executive Vice President, Global Chief Information Officer, The Cigna Group, resigned from the Company to pursue another opportunity, effective May 16, 2025. Ms. Eder’s decision to resign was due to personal reasons and was not a result of any disagreement with the Company.

   Read the 8-K filing
7. Apr 18, 2025

   On March 13, 2025, The Cigna Group (the “Company”) filed a Form 8-K disclosing that the employment of Eric P. Palmer, Executive Vice President for Enterprise Strategy, The Cigna Group and President and Chief Executive Officer, Evernorth Health Services, will end April 26, 2025. On April 15, 2025, the Company and Mr. Palmer executed an Agreement and Release (the “Agreement”). The Agreement includes customary confidentiality, non-solicitation, non-competition and non-disparagement provisions. In addition, the Agreement provides for a cash payment, subject to the terms of the release, of $5.2 million, reflective of: (1) 78 weeks of base pay; (2) 150% of Mr. Palmer’s 2025 Enterprise Incentive Plan (“EIP”) target; (3) a payment equal to Mr.

   Read the 8-K filing
8. Mar 13, 2025

   On March 13, 2025, The Cigna Group (the “Company”) announced certain leadership changes. Among these changes, effective March 31, 2025, Brian C. Evanko will serve as President and Chief Operating Officer, The Cigna Group and Ann M. Dennison will serve as Executive Vice President, Chief Financial Officer, The Cigna Group. Mr. Evanko, 48, has served as Executive Vice President and Chief Financial Officer, The Cigna Group and President and Chief Executive Officer, Cigna Healthcare since January 2024; Executive Vice President and Chief Financial Officer, The Cigna Group from January 2021 to January 2024; President, Government Business from November 2017 to January 2021; and President, U.S. Individual Business from August 2013 to November 2017.

   Read the 8-K filing
9. Jun 20, 2024

   On June 14, 2024, The Cigna Group (the “Company” or “our”) appointed Jamie Kates as the Company’s Chief Accounting Officer, serving as the Company’s principal accounting officer, effective July 1, 2024. Ms. Kates, 44, has served as Vice President, Accounting, since October 2021, pursuant to which she managed the Evernorth Health Services accounting, compliance and consolidation functions. Prior to that, she served as Managing Director, Accounting, from January 2019 through October 2021, during which she managed the Evernorth Health Services accounting and compliance functions. Ms. Kates joined The Cigna Group in 2009 and has held roles of increasing responsibility during her tenure. Ms. Kates is a Certified Public Accountant. In connection with her appointment, Ms. Kates accepted an offer letter, pursuant to which she will receive an annual base salary of $400,000.

   Read the 8-K filing
10. Jan 22, 2024

    On January 16, 2024, Mary Agoglia Hoeltzel, Senior Vice President and Chief Accounting Officer, notified The Cigna Group of her intention to retire, effective July 1, 2024.

    Read the 8-K filing
11. Jan 17, 2024

    On January 17, 2024, The Cigna Group (the “Company”) announced certain organizational changes. Among these changes, effective February 5, 2024: · Brian C. Evanko will serve as President and Chief Executive Officer, Cigna Healthcare, in addition to his current role as Executive Vice President and Chief Financial Officer, The Cigna Group. · Eric P. Palmer, currently President and Chief Executive Officer, Evernorth Health Services, will also assume responsibility for enterprise strategy and corporate development in the additional role of the Company’s Executive Vice President for Enterprise Strategy. On January 16, 2024, the People Resources Committee of the Company’s Board of Directors approved compensation changes for Mr. Evanko and Mr. Palmer to reflect the expansion of their roles and responsibilities. In connection with their respective expanded responsibilities, Mr. Evanko and Mr.

    Read the 8-K filing
12. Sep 15, 2023

    On September 14, 2023, The Cigna Group (the “Company”) approved compensation changes for Noelle K. Eder and Nicole S. Jones to reflect expansion of their roles and responsibilities. Ms. Eder, Executive Vice President, Technology and Operations, now leads the new Technology and Operations function , and Ms. Jones, Executive Vice President, Chief Administrative Officer and General Counsel, now also has responsibility for the Human Resources function. In connection with their respective expanded responsibilities, Mss. Eder and Jones received offer letters, the material terms of which are included in the table below. Mss. Eder and Jones will continue to be eligible to participate in the Company’s employee benefit plans, in accordance with their terms.

    Read the 8-K filing
13. May 1, 2023

    On April 26, 2023, the board of directors (the “Board”) of The Cigna Group (the “Company” or “our”) appointed Dr. Philip Ozuah as an independent member of our Board and to the People Resources and Compliance Committees, which appointments are effective June 1, 2023. Dr. Ozuah will participate in the Company’s non-employee director compensation program, amended and restated effective April 1, 2022 (the “Plan”), as described in our Proxy Statement for the 2023 Annual Meeting of Shareholders, filed with the Securities and Exchange Commission (the “SEC”) on March 17, 2023. A copy of the Plan has been filed as Exhibit 10.16(b) to the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 23, 2023. There is no arrangement or understanding between Dr. Ozuah and any other person pursuant to which Dr. Ozuah was selected as a director.

    Read the 8-K filing
14. Sep 23, 2021

    On September 20, 2021, Matthew G. Manders, President, Government & Solutions, and Timothy C. Wentworth, Chief Executive Officer, Evernorth, notified Cigna Corporation (the “Company”) of their intention to retire, effective December 3, 2021 and December 31, 2021, respectively. The terms of any retirement arrangement between the Company and Mr. Manders or the Company and Mr. Wentworth will be reported on a Form 8-K as required. On September 23, 2021, the Company announced the appointment of Eric P. Palmer as President and Chief Executive Officer, Evernorth, effective January 1, 2022. Mr.

    Read the 8-K filing
15. Jul 30, 2021

    Retirement of Isaiah Harris, Jr. On July 26, 2021, Isaiah Harris, Jr., the current Chair of the Board of Directors (the “Board”) of Cigna Corporation (“Cigna” or the “Company”), informed the Board that he intends to retire at the end of the year. Mr. Harris’s retirement is not a result of any disagreement with the Company. Appointment of Neesha Hathi On July 28, 2021, the Board appointed Neesha Hathi as an independent member of the Board, such appointment to be effective as of September 1, 2021. Ms. Hathi will serve on the Audit and Finance Committees. Ms. Hathi will receive compensation for her service on the Board pursuant to Cigna’s non-employee director compensation program as in effect from time to time during her service on the Board.

    Read the 8-K filing

Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021

From the company's 10-K XBRL data (SEC companyfacts).

People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.